RxDoctor Payments Data

Behnum Habibi, MD

Pain Medicine · Portland, ORNPI 1548656770

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Biotronik NRO, Inc. at 55.8% of the total. 2025 is the largest year on record at $2,595, more than ten times the $186 reported in 2019.

$3,241in general payments, 2019–2025

Across 31 payments — averaging $104.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biotronik NRO, Inc.$2K
  • Medtronic$438
  • Saluda Medical Americas, Inc.$242
  • Nevro Corp.$187
  • Vertex$136
  • Globus Medical$113
  • plus $318 from 5 others

What the payments were for

  • Consulting fees$1,36242%
  • Food & beverage$1,87958%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,241 in reported general payments places this provider in the 55th percentile of 57 pain medicine providers in Oregon.

See all pain medicine providers in Oregon

Medicare billing

Part B allowed, 2024
$23,593
Medicare patients
88
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin54$565
Duloxetine Hcl41$564
Diclofenac Sodium13$314
Meloxicam62$254
Gabapentin23$185
Venlafaxine Hcl ErVenlafaxine Hcl11$115
Cyclobenzaprine Hcl24$111
Ibuprofen12$45
Amitriptyline Hcl21$38

Paid to pharmacies, not to this prescriber.

Other pain medicine in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →